Invention Grant
- Patent Title: Methods of treating heart failure with hibernating myocardium using modified forms of trimetazidine
-
Application No.: US17540646Application Date: 2021-12-02
-
Publication No.: US12076318B2Publication Date: 2024-09-03
- Inventor: Jaikrishna Patel , Paul Chamberlin
- Applicant: IMBRIA PHARMACEUTICALS, INC.
- Applicant Address: US MA Boston
- Assignee: IMBRIA PHARMACEUTICALS, INC.
- Current Assignee: IMBRIA PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Boston
- Agency: Brown Rudnick LLP
- Agent Adam M. Schoen
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K9/00 ; A61K47/38
Abstract:
The invention provides methods of treatment of heart failure with hibernating myocardium using modified forms of trimetazidine, such as CV-8972 and CV-8814.
Public/Granted literature
- US20220184063A1 METHODS OF TREATING HEART FAILURE WITH HIBERNATING MYOCARDIUM USING MODIFIED FORMS OF TRIMETAZIDINE Public/Granted day:2022-06-16
Information query
IPC分类:
